S

Safeplus International Holdings Ltd
OTC:ACAI

Watchlist Manager
Safeplus International Holdings Ltd
OTC:ACAI
Watchlist
Price: 0.0008 USD
Market Cap: $20.3k

Safeplus International Holdings Ltd
Non-Reccuring Items

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Safeplus International Holdings Ltd
Non-Reccuring Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Non-Reccuring Items CAGR 3Y CAGR 5Y CAGR 10Y
S
Safeplus International Holdings Ltd
OTC:ACAI
Non-Reccuring Items
-$2.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Non-Reccuring Items
-$413m
CAGR 3-Years
12%
CAGR 5-Years
16%
CAGR 10-Years
10%
Edwards Lifesciences Corp
NYSE:EW
Non-Reccuring Items
-$531.4m
CAGR 3-Years
-94%
CAGR 5-Years
-6%
CAGR 10-Years
-54%
Stryker Corp
NYSE:SYK
Non-Reccuring Items
-$836m
CAGR 3-Years
3%
CAGR 5-Years
-4%
CAGR 10-Years
-8%
Abbott Laboratories
NYSE:ABT
Non-Reccuring Items
-$740m
CAGR 3-Years
-79%
CAGR 5-Years
N/A
CAGR 10-Years
-23%
Intuitive Surgical Inc
NASDAQ:ISRG
Non-Reccuring Items
-$9.8m
CAGR 3-Years
22%
CAGR 5-Years
9%
CAGR 10-Years
3%
No Stocks Found

Safeplus International Holdings Ltd
Glance View

Market Cap
20.3k USD
Industry
Health Care

Safeplus International Holdings Ltd. engages in the development of medical equipment, inventions, and technologies. The company is headquartered in Pittsford, New York and currently employs 2 full-time employees. The company went IPO on 2000-02-02. The firm is seeking to acquire an operating company or asset.

ACAI Intrinsic Value
Not Available
S

See Also

What is Safeplus International Holdings Ltd's Non-Reccuring Items?
Non-Reccuring Items
-2.1m USD

Based on the financial report for Feb 28, 2009, Safeplus International Holdings Ltd's Non-Reccuring Items amounts to -2.1m USD.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett